Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Cataract

In brief

The purpose of this study is to determine the safety and efficacy of C-KAD Ophthalmic Solution in improving visual acuity relative to placebo in patients with age-related cataract

Key facts

Study ID

NCT00793091

Run by

Chakshu Research, Inc.

People needed

80

Starts

2008-11-01

Expected to finish

2009-09-01

Last updated by the study team

2008-11-27

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Presence of age-related cataract in the study eye
• Best-corrected visual acuity of 20/25 to 20/50 in the study eye

You may not qualify if…

• Any other clinical condition in the eye that may compromise vision
• Presence or History of Glaucoma
• Presence or history of diabetes
• Use of eyedrops
• Use of steroids

Where it is running

• Pacific Eye Specialists — San Francisco, California, United States (enrolling)
• Hunkeler Eye Institute — Overland Park, Kansas, United States (enrolling)
• Minnesota Eye Consultants, PA — Minneapolis, Minnesota, United States (enrolling)
• Charlotte Eye, Ear, Nose & Throat Associates — Charlotte, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.